CLINICAL_TRIALS
trial_result
· 2026-02-04
Clinical Trial Update: Methylene Blue for the Treatment of Septic Shock [Phase 3]
Summary
Phase 3 trial of methylene blue for septic shock has completed, with the update indicating completion but no results are provided.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northern Jiangsu People's Hospital | Conditions: Septic Shock | Phase 3 | Status: COMPLETED